CY1111735T1 - Ιατρικο προϊον περιλαμβανον τιοτροπιο σε ενα υδατοστεγες δοχειο - Google Patents

Ιατρικο προϊον περιλαμβανον τιοτροπιο σε ενα υδατοστεγες δοχειο

Info

Publication number
CY1111735T1
CY1111735T1 CY20111100727T CY111100727T CY1111735T1 CY 1111735 T1 CY1111735 T1 CY 1111735T1 CY 20111100727 T CY20111100727 T CY 20111100727T CY 111100727 T CY111100727 T CY 111100727T CY 1111735 T1 CY1111735 T1 CY 1111735T1
Authority
CY
Cyprus
Prior art keywords
dose
tiotropium
moisture
container
medical product
Prior art date
Application number
CY20111100727T
Other languages
English (en)
Inventor
Thomas Nilsson
Mattias Myrman
Alf Niemi
Sven Calander
Original Assignee
Boehringer Ingelheim International Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29778162&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1111735(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim International Gmbh filed Critical Boehringer Ingelheim International Gmbh
Publication of CY1111735T1 publication Critical patent/CY1111735T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4748—Quinolines; Isoquinolines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Packages (AREA)
  • Materials For Medical Uses (AREA)
  • Table Devices Or Equipment (AREA)
  • Containers Having Bodies Formed In One Piece (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Η εφεύρεση αποκαλύπτει ένα ιατρικό προϊόν για χρήση στην αγωγή αναπνευστικών διαταραχών, και περιλαμβάνει μία μετρική δόση συστάσεως ξηρής κόνεως τιοτροπίου, άμεσα πληρωθείσας και σφραγισθείσας σε ένα δοχείο που έχει δημιουργηθεί ώστε να δρα ως ξηρός φραγμός υψηλής στεγανότητας για να αποτρέψει την παγίδευση και την είσοδο υγρασίας στην κόνη τιοτροπίου. Η δόση του τιοτροπίου είναι επιπλέον προσαρμοσμένη για εισπνοή και το δοχείο είναι τόσο στεγανό που η δραστικότητα της δόσεως όταν διανέμεται είναι ανεπηρέαστη από την υγρασία. Σε μία περαιτέρω όψη της εφευρέσεως απεικονίζεται ένα είδος εισπνευστήρα, που μπορεί να δεχθεί τουλάχιστον ένα σφραγισμένο, υδατοστεγές δοχείο μίας δόσεως τιοτροπίου, για τη διανομή της δόσεως με μία σταθερή δόση λεπτοδιαμερισμένων σωματιδίων, στο διάστημα της αναμενόμενης ημίσειας ζωής του προϊόντος.
CY20111100727T 2003-12-03 2011-07-22 Ιατρικο προϊον περιλαμβανον τιοτροπιο σε ενα υδατοστεγες δοχειο CY1111735T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0303269A SE0303269L (sv) 2003-12-03 2003-12-03 Medicinsk produkt
EP04801707A EP1706099B1 (en) 2003-12-03 2004-12-02 A medical product comprising tiotropium in a moisture-proof container

Publications (1)

Publication Number Publication Date
CY1111735T1 true CY1111735T1 (el) 2015-10-07

Family

ID=29778162

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20111100727T CY1111735T1 (el) 2003-12-03 2011-07-22 Ιατρικο προϊον περιλαμβανον τιοτροπιο σε ενα υδατοστεγες δοχειο

Country Status (25)

Country Link
US (4) US20050124644A1 (el)
EP (1) EP1706099B1 (el)
JP (1) JP2007513152A (el)
KR (1) KR101124071B1 (el)
CN (2) CN1913872B (el)
AT (1) ATE507821T1 (el)
AU (1) AU2004294886B2 (el)
BR (1) BRPI0417155A (el)
CA (1) CA2547781A1 (el)
CY (1) CY1111735T1 (el)
DE (1) DE602004032575D1 (el)
DK (1) DK1706099T3 (el)
ES (1) ES2362750T3 (el)
HK (1) HK1100643A1 (el)
IL (1) IL175887A (el)
MX (1) MXPA06006238A (el)
NZ (1) NZ547905A (el)
PL (1) PL1706099T3 (el)
PT (1) PT1706099E (el)
RU (1) RU2369385C2 (el)
SE (1) SE0303269L (el)
SG (1) SG148206A1 (el)
SI (1) SI1706099T1 (el)
WO (1) WO2005053644A1 (el)
ZA (4) ZA200604618B (el)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
US7080644B2 (en) 2000-06-28 2006-07-25 Microdose Technologies, Inc. Packaging and delivery of pharmaceuticals and drugs
ES2300568T3 (es) 2002-03-20 2008-06-16 Mannkind Corporation Aparato de inhalacion.
AU2004294889B2 (en) * 2003-12-03 2010-08-26 Boehringer Ingelheim International Gmbh Medical product containing tiotropium
SE0303270L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Metod för administration av tiotropium
SE0303569L (sv) * 2003-12-03 2005-06-04 Microdrug Ag DPI för avlämning av fuktkänsliga medikament
SE0303571D0 (sv) * 2003-12-03 2003-12-22 Microdrug Ag Medical product for moisture-sensitive medicaments
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
SE0303269L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Medicinsk produkt
AU2004294890B2 (en) * 2003-12-03 2010-08-26 Boehringer Ingelheim International Gmbh Pre-metered dry powder inhaler for moisture-sensitive medicaments
RU2372105C2 (ru) 2004-02-24 2009-11-10 Майкродоуз Текнолоджиз, Инк. Ингалятор с направленным датчиком потока
CA2575692C (en) 2004-08-20 2014-10-14 Mannkind Corporation Catalysis of diketopiperazine synthesis
KR20130066695A (ko) 2004-08-23 2013-06-20 맨카인드 코포레이션 약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
TWI274641B (en) * 2005-08-30 2007-03-01 Rexon Ind Corp Ltd Cutting machine
CN104324362B (zh) 2005-09-14 2018-04-24 曼金德公司 以提高活性试剂对结晶微粒表面的亲和力为基础的药物配制方法
MX2008010721A (es) 2006-02-22 2008-09-01 Mannkind Corp Un metodo para mejorar las propiedades farmaceuticas de microparticulas que contienen dicetopiperazina y un agente activo.
US9119777B2 (en) 2008-05-30 2015-09-01 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
US8415390B2 (en) 2008-05-30 2013-04-09 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
US8439033B2 (en) 2007-10-09 2013-05-14 Microdose Therapeutx, Inc. Inhalation device
US8371294B2 (en) 2008-02-29 2013-02-12 Microdose Therapeutx, Inc. Method and apparatus for driving a transducer of an inhalation device
US8424518B2 (en) 2008-06-13 2013-04-23 Mannkind Corporation Dry powder inhaler and system for drug delivery
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
EP2609954B1 (en) 2008-06-20 2021-12-29 MannKind Corporation An interactive apparatus for real-time profiling of inhalation efforts
TWI494123B (zh) 2008-08-11 2015-08-01 Mannkind Corp 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
ES2739352T3 (es) 2009-02-26 2020-01-30 Glaxo Group Ltd Formulaciones farmacéuticas que comprenden 4-{(1R)-2-[(6-{2-[(2,6-diclorobencil)oxi]etoxi}hexil)amino]-1-hidroxietil}-2-(hidroximetil)fenol
JP5667095B2 (ja) 2009-03-11 2015-02-12 マンカインド コーポレイション 吸入器の抵抗を測定するための装置、システムおよび方法
US8985101B2 (en) 2009-05-21 2015-03-24 Microdose Therapeutx, Inc. Method and device for clamping a blister within a dry powder inhaler
CA2762819C (en) 2009-05-21 2016-12-20 Microdose Therapeutx, Inc. Rotary cassette system for dry powder inhaler
KR20180036807A (ko) 2009-06-12 2018-04-09 맨카인드 코포레이션 한정된 비표면적을 갖는 디케토피페라진 마이크로입자
WO2011056889A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
CN105381524A (zh) 2010-01-05 2016-03-09 微剂量治疗技术公司 吸入设备和方法
CA2801936C (en) 2010-06-21 2021-06-01 Mannkind Corporation Dry powder drug delivery system and methods
CN103826988B (zh) 2011-04-01 2016-03-09 曼金德公司 用于药物药盒的泡罩包装
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
AU2012328885B2 (en) 2011-10-24 2017-08-31 Mannkind Corporation Methods and compositions for treating pain
AU2013289957B2 (en) 2012-07-12 2017-02-23 Mannkind Corporation Dry powder drug delivery systems and methods
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
BR112015010601B1 (pt) * 2012-11-09 2022-07-19 Civitas Therapeutics, Inc. Composição farmacêutica e uso da composição
CA2906817C (en) 2013-03-15 2022-01-18 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
MX2016000739A (es) 2013-07-18 2017-04-06 Mannkind Corp Composiciones farmacéuticas en polvo seco estables al calor y métodos.
CA2920488C (en) 2013-08-05 2022-04-26 Mannkind Corporation Insufflation apparatus and methods
WO2015148905A1 (en) 2014-03-28 2015-10-01 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
WO2018071434A1 (en) 2016-10-11 2018-04-19 Microdose Therapeutx, Inc. Inhaler and methods of use thereof

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6536427B2 (en) * 1990-03-02 2003-03-25 Glaxo Group Limited Inhalation device
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
US5544647A (en) * 1994-11-29 1996-08-13 Iep Group, Inc. Metered dose inhalator
US5692496A (en) * 1995-08-02 1997-12-02 Innovative Devices, Llc Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
WO1998029096A1 (en) * 1996-12-31 1998-07-09 Inhale Therapeutic Systems Aerosolized hydrophobic drug
CA2347856C (en) * 1998-11-13 2009-02-17 Jago Research Ag Dry powder for inhalation
US6270869B1 (en) * 1998-12-02 2001-08-07 Alusuisse Technology & Management Ltd. Cold formable laminate films
NZ515557A (en) * 1999-06-05 2003-10-31 Innovata Biomed Ltd Delivery system
DE60008425T2 (de) * 1999-10-11 2004-12-02 Innovata Biomed Ltd., St. Albans Medikamentenabgabevorrichtung mit einer feuchtigkeitsbeständigen beschichtung
SE9904706D0 (sv) * 1999-12-21 1999-12-21 Astra Ab An inhalation device
PE20011227A1 (es) * 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
GB0015043D0 (en) * 2000-06-21 2000-08-09 Glaxo Group Ltd Medicament dispenser
SE517227C2 (sv) * 2000-09-25 2002-05-14 Microdrug Ag Inhalator för torrt pulver med folieskärare
AU757008B2 (en) * 2000-10-12 2003-01-30 Boehringer Ingelheim Pharma Gmbh & Co. Kg Novel tiotropium-containing inhalation powder
IL155676A0 (en) * 2000-10-31 2003-11-23 Boehringer Ingelheim Pharma Inhalative solution formulation containing a tiotropium salt
DE10126924A1 (de) * 2001-06-01 2002-12-05 Boehringer Ingelheim Pharma Inhalationskapseln
US20030078947A1 (en) * 2001-10-12 2003-04-24 Intel Corporation Methods for assigning unique identifiers in a distributed fault tolerant application
US7258118B2 (en) * 2002-01-24 2007-08-21 Sofotec Gmbh & Co, Kg Pharmaceutical powder cartridge, and inhaler equipped with same
US6591832B1 (en) * 2002-02-21 2003-07-15 Saint-Gobain Calmar Inc. Dry powder dispenser
US20030235538A1 (en) * 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
UA80123C2 (en) * 2002-04-09 2007-08-27 Boehringer Ingelheim Pharma Inhalation kit comprising inhalable powder of tiotropium
SE525027C2 (sv) * 2002-04-12 2004-11-16 Microdrug Ag Anordning utgörande en pulverlufthyvel
SE524957C2 (sv) * 2002-04-12 2004-11-02 Microdrug Ag Förfarande för uppdelning och fördelning i luft av torrt pulvermedikament
SE524990C2 (sv) * 2002-04-12 2004-11-09 Microdrug Ag Preparation av terapeutiskt torrt pulver samt förfarande för uppdelning och spridning i luft av medicinskt pulver
GB0225621D0 (en) * 2002-11-02 2002-12-11 Glaxo Group Ltd Medicament carrier
CN1292748C (zh) * 2003-03-05 2007-01-03 南昌弘益科技有限公司 噻托溴铵吸入粉雾剂及其制备工艺
WO2005016558A2 (en) * 2003-08-04 2005-02-24 Microchips, Inc. Methods for accelerated release of material from a reservoir device
SE0303571D0 (sv) * 2003-12-03 2003-12-22 Microdrug Ag Medical product for moisture-sensitive medicaments
SE0303270L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Metod för administration av tiotropium
SE0303269L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Medicinsk produkt
SE0303569L (sv) * 2003-12-03 2005-06-04 Microdrug Ag DPI för avlämning av fuktkänsliga medikament
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt

Also Published As

Publication number Publication date
ATE507821T1 (de) 2011-05-15
US20060257327A1 (en) 2006-11-16
CA2547781A1 (en) 2005-06-16
BRPI0417155A (pt) 2007-03-06
PL1706099T3 (pl) 2011-10-31
RU2369385C2 (ru) 2009-10-10
JP2007513152A (ja) 2007-05-24
EP1706099B1 (en) 2011-05-04
MXPA06006238A (es) 2006-08-23
ZA200604618B (en) 2009-03-25
AU2004294886B2 (en) 2009-12-03
KR20060109933A (ko) 2006-10-23
US20090192185A1 (en) 2009-07-30
CN1913873A (zh) 2007-02-14
US20090041682A1 (en) 2009-02-12
SE0303269D0 (sv) 2003-12-03
SI1706099T1 (sl) 2011-07-29
ZA200605380B (en) 2008-05-28
SE0303269L (sv) 2005-06-04
AU2004294886A1 (en) 2005-06-16
WO2005053644A8 (en) 2006-12-14
KR101124071B1 (ko) 2012-03-20
HK1100643A1 (en) 2007-12-07
DE602004032575D1 (de) 2011-06-16
ZA200605379B (en) 2008-07-30
IL175887A0 (en) 2006-10-05
RU2006122849A (ru) 2008-01-10
PT1706099E (pt) 2011-06-08
WO2005053644A1 (en) 2005-06-16
DK1706099T3 (da) 2011-06-27
US20050124644A1 (en) 2005-06-09
SG148206A1 (en) 2008-12-31
ZA200604616B (en) 2009-03-25
ES2362750T3 (es) 2011-07-12
CN1913873B (zh) 2011-05-18
CN1913872B (zh) 2011-05-25
EP1706099A1 (en) 2006-10-04
NZ547905A (en) 2009-06-26
CN1913872A (zh) 2007-02-14
IL175887A (en) 2011-02-28

Similar Documents

Publication Publication Date Title
CY1111735T1 (el) Ιατρικο προϊον περιλαμβανον τιοτροπιο σε ενα υδατοστεγες δοχειο
SE0402976L (sv) Medicinsk produkt
HK1104000A1 (en) Pre-metered dry powder inhaler for moisture-sensitive medicaments
MX2010008234A (es) Nueva dosificacion y formulacion.
MX2010008235A (es) Nueva dosificacion y formulacion.
WO2006008517A3 (en) Use of dry powder compositions for pulmonary delivery
ATE441402T1 (de) Verbessertes medizinprodukt
WO2008106689A3 (en) Breakthrough pain management
WO2005041921A3 (en) Dry powder compositions for inhalation therapy comprising calcium stearate, medical devices therefor
MD20140131A2 (ro) Doză şi formă preparativă nouă pentru inhalare care cuprinde aclidiniu
SE0402345D0 (sv) A metered medication dose
MX2015015150A (es) Composiciones farmaceuticas inhalables y los dispositivos inhaladores que las contienen.
EA200500387A1 (ru) Композиции для ингаляции с высоким содержанием лекарственных веществ
TH100283A (th) เครื่องช่วยหายใจแบบใช้ผง